+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cellulite Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • PDF Icon


  • 120 Pages
  • January 2022
  • Region: Global
  • Mordor Intelligence
  • ID: 4987206

The cellulite treatment market studied was anticipated to grow with a CAGR of nearly 7.9% during the forecast period. The major factors attributing to the growth of the market are a rise in the sedentary lifestyle, inactivity, and poor dietary habits resulting in cellulite formation and increased obese population. For instance, according to the World Health Organization report, in 2016, about 650 million adults and 41 million children aged under 5 years were obese worldwide which is expected to grow during the forecast period fueling the market. Furthermore, the formation of cellulite affects an individual's psychological, behavioral, and psychiatric characteristics that are more in developed economies drive the market growth in the forecast period.

Key Market Trends

Non-invasive Procedure segment is Expected to Hold the Major Market Share in the Cellulite Treatment Market

The Non-invasive Procedure segment dominated the market in recent years and is expected to do so over the forecast period due to high demand from specialized dermatology clinics and hospitals owing to the preference of the patients and physicians. Next to the non-invasive segment, the topical products segment witnesses the highest growth rate in terms of market revenue share due to their increasing demand owing to their ease of application without physician’s assistance and availability of the wide range of products offered for the treatment which drives the growth of the segment.

The energy-based treatment segment is expected to dominate over the forecast time period, owing to the various advancements witnessed in energy-based devices that allow less painful and more secure and efficient medical aesthetic procedures. Most energy-based devices are non-invasive in nature, and are considered to be safer and have a lower risk of therapy with restricted post-procedural downtime as compared to traditional invasive surgical procedures.

Based on cellulite, the soft cellulite segment is expected to witness a significant growth rate over the forecast period as this cellulite can be treated easily compared to the other forms of cellulite.

Based on the end-user, specialized dermatology clinics segment held the largest market share in recent years and are expected to remain dominant in the global market. The dominance can be attributed to the long-term success rates of therapy due to the availability of skilled and certified professionals specific to the target area at these clinics which reduces the risk of complication.

North America Dominates the Market and Expected to do Same in the Forecast Period.

North America has been the primary market for cellulite treatment, owing to the rise in the number of obesity cases due to a sedentary lifestyle and an increase in the adoption of advanced technologies in the region. A rise in a shift towards the Non-invasive treatments from surgical procedures has been increased in recent years. For instance, according to the 2018 Plastic Surgery Statistics, 5.8 million reconstructive procedures were recorded worldwide which was decreased past couple years indicating the preference for Non-invasive treatments fueling the market in the region.

Globally, the cellulite treatment market is expected to witness the fastest growth in Asia-Pacific during the forecast period due to the increasing inclination towards technological advancements and R&D activities in China and India. Furthermore, a rise in awareness and preference for MIS techniques and various types of cellulite treatment is expected to fuel cellulite treatment market growth in the forecast period.

Competitive Landscape

The Cellulite Treatment Market is moderately competitive and consists of several major players. In terms of market revenue share, a few of the key players are currently dominating the market. Some prominent players are launching new products, while others are distributing the products. For instance, in March 2017, Hologic Inc, a leader in women's healthcare systems acquired Cynosure, a leading medical aesthetics systems manufacturer and established a strong footprint in the rapidly growing medical aesthetics market and consolidate its market positions across the globe thereby increasing the global market revenue. Some of the companies which are currently dominating the market are Merz Pharma GmbH & Co. KGaA, Cutera Inc, Hologic Inc, Candela Corporation, and Inceler Medikal Co Ltd.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 The Rise in Prevalence of Obesity Cases
4.2.2 I Increased Relucatance towards Surgical Procedures
4.3 Market Restraints
4.3.1 Less Awareness about Cellulite Treatment in Emerging Countries
4.3.2 Adoption of Substituent Traditional and Herbal Massage Therapies
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 Procedure
5.1.1 Minimally Invasive
5.1.2 Non-Invasive
5.1.3 Topical
5.2 Cellulite
5.2.1 Soft Cellulite
5.2.2 Hard Cellulite
5.2.3 Edematous Cellulite
5.3 End-User
5.3.1 Hospitals
5.3.2 Cosmetic Surgery Centers
5.3.3 Specialized Dermatology Clinics
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle East and Africa GCC South Africa Rest of Middle East and Africa
5.4.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Merz Pharma GmbH & Co KGaA
6.1.2 Inceler Medikal Co Ltd
6.1.3 Candela Corporation
6.1.4 Hologic Inc
6.1.5 Cutera Inc
6.1.6 Nestle S A
6.1.7 Tanceuticals LLC
6.1.8 Zimmer Aesthetics
6.1.9 cymedics GmbH & Co KG
6.1.10 Beijing Nubway S&T Co Ltd

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Merz Pharma GmbH & Co KGaA
  • Inceler Medikal Co Ltd
  • Candela Corporation
  • Hologic Inc
  • Cutera Inc
  • Nestle S A
  • Tanceuticals LLC
  • Zimmer Aesthetics
  • cymedics GmbH & Co KG
  • Beijing Nubway S&T Co Ltd